NASDAQ:IMTXW

immatics biotechnologies (IMTXW) Stock Forecast, Price & News

$3.58

-0.17 (-4.53%)

(As of 09/21/2023 ET)

Compare

Today's Range: $3.58
▼
$3.58
50-Day Range: $3.07
▼
$3.91
52-Week Range: $1.20
▼
$4.14

Volume: 300 shs
Average Volume: 17,866 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Financials Institutional Ownership SEC Filings Short Interest Social Media

About immatics biotechnologies (NASDAQ:IMTXW) Stock

immatics is a clinical-stage biopharmaceutical company active in the discovery and development of t-cell redirecting immunotherapies for the treatment of cancer. our transformative product candidates are - best in class - adoptive cell therapies and bispecific tcr molecules. these products are directed against tumor targets that have been identified and validated by immatics' proprietary and world-leading xpresident® technology. our mission is to bring the power of t-cell redirecting immunotherapies to cancer patients. quick facts - 150 team members - >100 targets covering 20 major solid and liquid tumors - about 80% of discovered targets are novel - 2 proprietary technology platforms - 8 proprietary development programs, thereof 2 in the clinic in 2017 - multiple partnered programs - raised more than $230m in cash in five financings read more about immatics on our homepage: https://immatics.com/ find us on twitter and xing: twitter: http://bit.ly/2dfbpre xing: http://bit.ly/2e1kkpv l

IMTXW Price History

30 days | 90 days | 365 days | Advanced Chart

IMTXW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive IMTXW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for immatics biotechnologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biological Product (except Diagnostic) Manufacturing
Sub-Industry: N/A
Sector: Manufacturing
Current Symbol: NASDAQ:IMTXW
CUSIP: N/A
CIK: 1809196
Web: immatics.com
Phone: 4970715397700
Fax: N/A
Employees: 381
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $84.86 million
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 Best Stocks to Own in 2023

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

IMTXW Stock - Frequently Asked Questions

How have IMTXW shares performed in 2023?: immatics biotechnologies' stock was trading at $2.51 at the start of the year. Since then, IMTXW stock has increased by 42.6% and is now trading at $3.58.
View the best growth stocks for 2023 here.
Are investors shorting immatics biotechnologies?: immatics biotechnologies saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 14,100 shares, an increase of 15.6% from the August 15th total of 12,200 shares. Based on an average trading volume of 16,100 shares, the short-interest ratio is currently 0.9 days.
View immatics biotechnologies' Short Interest.
What is immatics biotechnologies' stock symbol?: immatics biotechnologies trades on the NASDAQ under the ticker symbol "IMTXW."
Who are immatics biotechnologies' major shareholders?: immatics biotechnologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Aristeia Capital LLC (0.00%), Privium Fund Management B.V. (0.00%), 683 Capital Management LLC (0.00%), JPMorgan Chase & Co. (0.00%) and Walleye Capital LLC (0.00%).

How do I buy shares of immatics biotechnologies?: Shares of IMTXW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is immatics biotechnologies' stock price today?: One share of IMTXW stock can currently be purchased for approximately $3.58.
How many employees does immatics biotechnologies have?: The company employs 381 workers across the globe.
How can I contact immatics biotechnologies?: immatics biotechnologies' mailing address is Paul Ehrlich-Strasse 15, Tuebingen, Baden Wuerttemberg 72076. The official website for the company is immatics.com. The company can be reached via phone at 4970715397700.

This page (NASDAQ:IMTXW) was last updated on 9/22/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial